BRAF Fusion
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors (NCT04985604) | Day One Biopharmaceuticals, Inc. | 2021-07-15 |
Track BRAF Fusion automatically
Every clearance here is in the API, with alerts when new ones post.